Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cynobac
- Development stage
- Unknown
- Lead developer
- Strassenburg Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Cynobac is an oral probiotic and vitamin supplement developed and marketed by Strassenburg Pharmaceuticals. It is formulated as a tablet containing Lactic Acid Bacillus (Lactobacillus sporogenes), Folic Acid, and Vitamin B12 (Cyanocobalamin). Cynobac is primarily indicated for the management and prevention of antibiotic-associated diarrhea, irritable bowel syndrome, and traveler's diarrhea. The probiotic component helps restore the natural balance of gut microbiota disrupted by antibiotics or infections, while Folic Acid and Vitamin B12 support red blood cell formation, DNA synthesis, and neurological health.
- Brand names
- CynobacCynobac TabletCynobac Tender
- Other names
- cyanocobalamin + folic acid + lactic acid bacillusfolic acid + lactic acid bacillus + vitamin B12lactobacillus sporogenes + folic acid + vitamin B12
Beyond the preview
Go deeper on Cynobac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cynobac.